Rock Springs Capital

Co-founder of Rock Springs Capital with medical and business background. Previously a vice president at T. Rowe Price covering medical device and biotechnology companies, and co-founded Rivanna Pharmaceuticals. Holds an M.D. from the University of Virginia, M.B.A. from Darden, and a B.A. in chemistry and biology from Williams College.

Partner at Rock Springs Capital since inception with a decade of experience as a research associate at T. Rowe Price analyzing medical device and biotechnology companies. Holds a B.S. in Business Administration from Salisbury University, an M.B.A. from Loyola University, and the Chartered Financial Analyst designation.

General Counsel and Chief Compliance Officer at Rock Springs Capital. Previously served as Chief Regulatory Counsel and Chief Compliance Officer at SoftBank Investment Advisers and as Associate General Counsel at a large publicly traded financial services company. Began his legal career at Skadden, Arps and worked as Senior Counsel at the SEC in the Division of Investment Management. Holds a J.D. from Georgetown Law School.

Joined Rock Springs Capital in 2025 with expertise in biomedical engineering. Completed a Ph.D. in Biomedical Engineering at Johns Hopkins where she also interned at Johns Hopkins Technology Ventures evaluating early-stage startups and managed operations of technology commercialization funds. Holds an M.S. and B.S. in Biomedical Engineering and Mathematics from Johns Hopkins and University of Virginia respectively.

Joined Rock Springs Capital in 2021 with prior experience in business development at Cabaletta Bio, a clinical-stage biotechnology company that completed Series A, B, and IPO. Also performed graduate research at the National Institutes of Health. Holds a B.S. in Economics from Wharton and a B.A. in Biology from the University of Pennsylvania.

Joined Rock Springs Capital in 2024 with a background in healthcare entrepreneurship and consulting. Founded and sold a cloud-based practice management solution and previously worked at McKinsey advising clients across payor, provider, medical device, and pharmaceutical sectors. Holds an M.D. from Yale and a bachelor's degree from Harvard.

Director of Investor Relations at Rock Springs Capital. Previously served as Director of Business Development at Select Equity Group and held institutional sales roles at Schroders Investment Management and BNY Mellon Investment Management. Holds a B.S. in Broadcasting and Film from Boston University.

Chief Financial Officer at Rock Springs Capital since 2016. Previously served as Vice President of Finance at Grand Brands and as a Corporate Tax Accountant at T. Rowe Price. Holds a B.A. in International Comparative Studies from Duke University and the CPA and CMA designations.

Controller at Rock Springs Capital since 2019. Previously served as Assistant Controller at Greenspring Associates, a venture capital firm in Maryland, and as an audit associate at CohnReznick LLP. Holds a B.S. in Accounting from Mount St. Mary's University and the CPA designation.

Joined Rock Springs Capital in 2024 as an investment analyst covering MedTech and healthcare services. Previously worked at Alyeska Investment Group in healthcare coverage. Holds a B.S. from Oklahoma State University, an M.B.A. from Wharton, and an M.P.A. from Harvard Kennedy School. Has aerospace engineering background from American Airlines.

Joined Rock Springs Capital in 2024. Completed undergraduate studies at Johns Hopkins University with dual degrees in Materials Science and Engineering and Cognitive Science. Previously served in the Singapore Armed Forces, reaching the rank of Lieutenant.